Signal Transduction in Atherosclerosis
Signal Transduction in Atherosclerosis
批准号:
8492128
负责人:
GARRET A FITZGERALD
金额:
$215.86万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-04-07 至 2014-06-30
关键词:
AddressAgeAortaApolipoprotein EArterial Fatty StreakAtherosclerosisAttentionBiologicalBiological ModelsBlood PlateletsBlood VesselsCD44 geneCardiac MyocytesCardiovascular DiseasesCardiovascular PhysiologyCause of DeathCell CycleCellsCellular biologyChemicalsComplementComplexDevelopmental ProcessDiseaseEmployee StrikesEndothelial CellsEnzymesEquilibriumExtracellular MatrixFamily suidaeFosteringFundingGenderGenomicsGrantHeadHeterogeneityHumanImmunohistochemistryIncidenceInflammationInstitutesInterdisciplinary StudyLeadLesionMechanicsMediator of activation proteinMetabolic syndromeModelingNaturePTGS2 genePathogenesisPathway interactionsPennsylvaniaPhenotypePredispositionProteomicsPublic HealthPublicationsResearch PersonnelRisk FactorsRodentRoleSeasonsSignal PathwaySignal TransductionSmooth Muscle MyocytesSystemTechnologyTestingThrombosisUnited StatesUniversitiesWorkatherogenesisbasedata integrationinsightmacrophagemetabolomicsmouse PGE synthase 1mouse modelnovelnovel strategiesnovel therapeuticsprogramsstructural biology
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This highly integrated program is focused on the study of factors influencing discrete regional susceptibility to atherogenesis. The complex interplay of mechanical forces and chemical mediators which impinge on platelet vascular interactions and on cells of the vessel wall and their interaction with the extracellular matrix will be elucidated. Distinct and overlapping signaling pathways will be integrated by genomic and proteomic interrogation of determinants of the balance between susceptibility to and protection from atherosclerosis. Particular attention will be paid to how traditional risk factors, including age, hyperiipidemia and gender condition cell signaling pathways of relevance to inflammation and the cell cycle. In Project 1 the role of COX-2 and mPGES-1, will be assessed. Novel mouse models will delineate their contribution in endothelial, vascular smooth muscle cells, macrophages and cardiomyocytes to cardiovascular function. A priori hypothesis testing will complement unbiased approaches to assess the impact of enzyme disruption on discrete phenotypes and biological networks. In Project 4 the interaction between the ApoE/COX-2/PGl2/IP pathway and the cell cycle will be probed, using cell specific deletions and forced expression of COX-2, deletion, antagonism and stimulation of the IP and by using biophysical approaches to assess differential impact on the extracellular matrix. Finally, in Project 5 we shall examine the effect of gender and hyperiipidemia on the discrete expression of genomic subsets in endothelial cells obtained from regions of the pig aorta susceptible to and protected from atherogenesis. This program will take an integrated approach to the study of humoral and mechanical signaling in vascular cells. Factors that underlie the cell to cell heterogeneity of this interaction are likely to contribute to the focal nature of atherogenesis.
期刊论文(94)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1038/clpt.2012.3
发表时间:
2012-06
期刊:
Clinical pharmacology and therapeutics
影响因子:
6.7
作者:
[]
通讯作者:
DOI:
10.1126/scisignal.2004838
发表时间:
2014-06-17
期刊:
Science signaling
影响因子:
7.3
作者:
[Bae YH, Mui KL, Hsu BY, Liu SL, Cretu A, Razinia Z, Xu T, Puré E, Assoian RK]
通讯作者:
Assoian RK
Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma.
15-脱氧-delta12,14-PGJ2 的生物合成和 PPARgamma 的连接。
DOI:
10.1172/jci18012
发表时间:
2003
期刊:
The Journal of clinical investigation.
影响因子:
--
作者:
[Bell-Parikh,LChastine, Ide,Tomomi, Lawson,JohnA, McNamara,Peter, Reilly,Muredach, FitzGerald,GarretA]
通讯作者:
FitzGerald,GarretA
A new approach to the synthesis of polyunsaturated deuterated isoprostanes: total synthesis of d4-5-epi-8,12-iso-iPF3alpha-VI and d4-8,12-iso-iPF3alpha-VI.
多不饱和氘代异前列烷合成新方法:d4-5-epi-8,12-iso-iPF3alpha-VI和d4-8,12-iso-iPF3alpha-VI的全合成。
DOI:
10.1016/j.bmcl.2009.09.099
发表时间:
2009
期刊:
Bioorganic & medicinal chemistry letters
影响因子:
2.7
作者:
[Chang,Chih-Tsung, Patel,Pranav, Gore,Vivek, Song,Wen-Liang, Lawson,JohnA, Powell,WilliamS, Fitzgerald,GarretA, Rokach,Joshua]
通讯作者:
Rokach,Joshua
DOI:
10.1161/atvbaha.109.198549
发表时间:
2010-02
期刊:
Arteriosclerosis, thrombosis, and vascular biology
影响因子:
--
作者:
[Guerraty MA, Grant GR, Karanian JW, Chiesa OA, Pritchard WF, Davies PF]
通讯作者:
Davies PF
共 46 条
Institutional Clinical and Translational Sciences Award
-
批准号:10487653
-
项目类别:
-
资助金额:$6.13万
-
财政年份:2022
-
负责人:GARRET A FITZGERALD
-
依托单位:
Atherosclerosis, Prostaglandin Inhibition and Checkpoint Blockade
-
批准号:10304145
-
项目类别:
-
资助金额:$65.41万
-
财政年份:2019
-
负责人:GARRET A FITZGERALD
-
依托单位:
Atherosclerosis, Prostaglandin Inhibition and Checkpoint Blockade
-
批准号:10065018
-
项目类别:
-
资助金额:$66.99万
-
财政年份:2019
-
负责人:GARRET A FITZGERALD
-
依托单位:
Institutional Clinical and Translational Science Award
-
批准号:10348879
-
项目类别:
-
资助金额:$1016.45万
-
财政年份:2016
-
负责人:GARRET A FITZGERALD
-
依托单位:
Institutional Clinical and Translational Science Award
-
批准号:9261656
-
项目类别:
-
资助金额:$998.54万
-
财政年份:2016
-
负责人:GARRET A FITZGERALD
-
依托单位:
Phenotypic Diversity in COVID-19
-
批准号:10158887
-
项目类别:
-
资助金额:$63.39万
-
财政年份:2016
-
负责人:GARRET A FITZGERALD
-
依托单位:
Institutional Clinical and Translational Science Award
-
批准号:10646280
-
项目类别:
-
资助金额:$1024.77万
-
财政年份:2016
-
负责人:GARRET A FITZGERALD
-
依托单位:
Institutional Clinical and Translational Science Award
-
批准号:9562973
-
项目类别:
-
资助金额:$1000.41万
-
财政年份:2016
-
负责人:GARRET A FITZGERALD
-
依托单位:
Institutional Clinical and Translational Science Award
-
批准号:10426378
-
项目类别:
-
资助金额:$1026.02万
-
财政年份:2016
-
负责人:GARRET A FITZGERALD
-
依托单位:
Institutional Clinical and Translational Science Award
-
批准号:10227357
-
项目类别:
-
资助金额:$16.19万
-
财政年份:2016
-
负责人:GARRET A FITZGERALD
-
依托单位:
Institutional Clinical and Translational Science Award
-
批准号:10455191
-
项目类别:
-
资助金额:$17.75万
-
财政年份:2016
-
负责人:GARRET A FITZGERALD
-
依托单位:
Personalization of Therapeutic Efficacy and Risk
-
批准号:8093372
-
项目类别:
-
资助金额:$373.63万
-
财政年份:2012
-
负责人:GARRET A FITZGERALD
-
依托单位:
Personalization of Therapeutic Efficacy and Risk
-
批准号:8689159
-
项目类别:
-
资助金额:$369.97万
-
财政年份:2012
-
负责人:GARRET A FITZGERALD
-
依托单位:
Personalization of Therapeutic Efficacy and Risk
-
批准号:8516094
-
项目类别:
-
资助金额:$372.04万
-
财政年份:2012
-
负责人:GARRET A FITZGERALD
-
依托单位:
Core A: Administrative
-
批准号:8126749
-
项目类别:
-
资助金额:$31.14万
-
财政年份:2012
-
负责人:GARRET A FITZGERALD
-
依托单位:
Personalization of Therapeutic Efficacy and Risk
-
批准号:9069494
-
项目类别:
-
资助金额:$366.61万
-
财政年份:2012
-
负责人:GARRET A FITZGERALD
-
依托单位:
CTSA INFRASTRUCTURE FOR PEDIATRIC CLINICAL TRIALS
-
批准号:8365016
-
项目类别:
-
资助金额:$249.44万
-
财政年份:2011
-
负责人:GARRET A FITZGERALD
-
依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:8365017
-
项目类别:
-
资助金额:$78.55万
-
财政年份:2011
-
负责人:GARRET A FITZGERALD
-
依托单位:
Animal Models and Drug Discovery
-
批准号:8205110
-
项目类别:
-
资助金额:$3.5万
-
财政年份:2011
-
负责人:GARRET A FITZGERALD
-
依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:8365018
-
项目类别:
-
资助金额:$78.55万
-
财政年份:2011
-
负责人:GARRET A FITZGERALD
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: